1. Lewis acid-promoted synthesis of highly substituted pyrrole-fused benzoxazinones and quinoxalinones
   Suresh Selvendran et al, 2021, Synthetic Communications CrossRef
2. Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)
   Rama Rathore et al, 2017, Apoptosis CrossRef
3. Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL
   Ali Hassanzadeh et al, 2018, Journal of Cellular Physiology CrossRef
4. Appraisal of pyrrole as connecting unit in hydroxamic acid based histone deacetylase inhibitors: Synthesis, anticancer evaluation and molecular docking studies
   Avineesh Singh et al, 2021, Journal of Molecular Structure CrossRef
5. One-Pot Synthesis of Diverse Collections of Benzoxazepine and Indolopyrazine Fused to Heterocyclic Systems
   Vunnam Srinivasulu et al, 2019, The Journal of Organic Chemistry CrossRef
6. Modular Bi‐Directional One‐Pot Strategies for the Diastereoselective Synthesis of Structurally Diverse Collections of Constrained β‐Carboline‐Benzoxazepines
   Vunnam Srinivasulu et al, 2017, Chemistry – A European Journal CrossRef
7. An efficient synthesis of 16H-dibenzo[2,3:6,7][1,4]oxazepino[5,4-b]quinazolin-16-ones via an Ullmann reaction catalyzed by CuI
   Yan Zhang et al, 2018, Organic & Biomolecular Chemistry CrossRef
8. TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies
   Adel Naimi et al, 2018, Biomedicine & Pharmacotherapy CrossRef
9. 1,5‐Benzoxazepines as a unique and potent scaffold for activity drugs: A review
   Monika Stefaniak et al, 2021, Archiv der Pharmazie CrossRef
10. Retracted: Dasatinib promotes TRAIL‐mediated apoptosis by upregulating CHOP‐dependent death receptor 5 in gastric cancer
    Xiaona Wang et al, 2018, FEBS Open Bio CrossRef
11. A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis
    Francesca Vanni et al, 2021, Pharmacological Research CrossRef
12. Indole-fused azepines and analogues as anticancer lead molecules: Privileged findings and future directions
    Ashok K. Singh et al, 2017, European Journal of Medicinal Chemistry CrossRef
13. Tubulin couples death receptor 5 to regulate apoptosis
    Julianne D. Twomey et al, 2018, Oncotarget CrossRef
14. A Jocic-type approach for a practical and scalable synthesis of pyrrolonaphthoxazepine (PNOX)-based potent proapoptotic agents
    Stefano Federico et al, 2018, Tetrahedron Letters CrossRef
15. Synthesis of tetracyclic pyrido-fused dibenzodiazepines via a catalyst-free cascade reaction
    Abdolali Alizadeh et al, 2021, Molecular Diversity CrossRef
16. Knockdown of GPSM1 Inhibits the Proliferation and Promotes the Apoptosis of B-Cell Acute Lymphoblastic Leukemia Cells by Suppressing the ADCY6-RAPGEF3-JNK Signaling Pathway
    Ye Zhang et al, 2021, Pathology and Oncology Research CrossRef
17. RETRACTED: Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
    Ehsan Razeghian et al, 2021, Frontiers in Immunology CrossRef
18. A Synthetic Overview of Benzoxazines and Benzoxazepines as Anticancer Agents
    Indranil Chatterjee et al, 2023, ChemMedChem CrossRef
19. Design and Synthesis of Novel Functionalized Fused Oxazepine and Diazepine Analogues Containing Coumarin Backbone through Domino Reaction
    Samane Poursan et al, 2019, ChemistrySelect CrossRef
20. Telmisartan generates ROS-dependent upregulation of death receptor 5 to sensitize TRAIL in lung cancer via inhibition of autophagy flux
    Mohammad Rasheduzzaman et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
21. Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents
    Margherita Brindisi et al, 2019, European Journal of Medicinal Chemistry CrossRef